Text Size
2 studies found for:    Ustekinumab crohn's phase 3 | Open Studies

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Ustekinumab crohn's phase 3 | Open Studies (2 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
Conditions: Crohn's Disease;   Inflammatory Bowel Disease;   IBD;   Colitis
Interventions: Drug: Group 3: ustekinumab approximately 6 mg/kg;   Drug: Group 1: Placebo;   Drug: Group 2 ustekinumab 130 mg
2 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
Conditions: Crohn's Disease;   Colitis;   IBD;   Inflammatory Bowel Disease
Interventions: Drug: Placebo;   Drug: Ustekinumab
To Top

† Indicates status has not been verified in more than two years